Allergic Respiratory Diseases Award
This funding opportunity supports early-career researchers in Clinical Allergy and Immunology at U.S. academic medical centers to advance research and improve patient outcomes in allergic respiratory diseases.
The Allergic Respiratory Diseases Research Award is a joint initiative between the American Lung Association and the American Academy of Allergy, Asthma & Immunology (AAAAI). This funding opportunity aims to support researchers affiliated with Clinical Allergy and Immunology divisions of academic medical centers, with the goal of advancing understanding and improving outcomes in allergic respiratory disease. The program particularly targets researchers at pivotal points in their careers and emphasizes institutional commitment to the applicant’s professional development. The award offers $75,000 per year for up to two years. It supports research projects that focus on allergic respiratory diseases with the aim of enhancing patient care and outcomes. Eligible applicants must hold a doctoral degree, be fully trained, and occupy a full-time faculty or professional appointment in a Clinical Allergy and Immunology division. Those outside of such divisions or institutions without such departments are not eligible. Up to 75% of the grant may be allocated toward the awardee’s salary and fringe benefits, and no more than 30% may be used for purchasing permanent equipment. Funding for the second year is contingent upon satisfactory progress and continued availability of funds. Eligible candidates must be U.S. citizens or hold valid visa status and be employed by a U.S. institution. Priority is given to applicants below the rank of associate professor and those who have not received more than one NIH R series award. Applications are reviewed by a panel that includes representatives from both sponsoring organizations, focusing on scientific merit, applicant qualifications, research environment, and long-term career potential in lung health research. Applications must be submitted through ProposalCentral, with the portal opening on August 7, 2024, and closing on December 6, 2024, at 11:59 PM Eastern Time. Peer review will occur from January to April 2025, and notifications will be sent in June 2025. The research term begins on July 1, 2025. Applicants are required to provide several documents, including a detailed research plan, budget, three letters of recommendation, and a department head statement. Ethical compliance regarding human subjects, animals, and biohazards must be confirmed. Projects must align with federal standards and cannot overlap budgetarily with other funded work. Detailed instructions and templates for completing the application are provided within the ProposalCentral system.
Award Range
$75,000 - $75,000
Total Program Funding
Not specified
Number of Awards
Not specified
Matching Requirement
No
Additional Details
Eligible applicants must have a primary faculty appointment in an allergy-immunology division. Applicants must have held an NIH K- or R-type award within the past five years, but no more than two R01 type grants. Eligible applicants must have held an NIH K- or R-type award within the last five years, with a limit of two R01 type grants.
Eligible Applicants
Additional Requirements
Eligible applicants must have a primary faculty appointment in an allergy-immunology division. Eligible applicants must have held an NIH K- or R-type award within the past five years, but no more than two R01 type grants. Eligible applicants must have held an NIH K- or R-type award within the last five years, with a limit of two R01 type grants.
Geographic Eligibility
All
Application Opens
August 7, 2026
Application Closes
Not specified
Grantor
American Academy of Allergy, Asthma & Immunology
Subscribe to view contact details
Subscribe to access grant documents